Related Experiment Video
Updated: May 1, 2026
Combined Immunofluorescence and DNA FISH on 3D-preserved Interphase Nuclei to Study Changes in 3D Nuclear Organization
Published on: February 3, 2013
Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex
Arthur Jorge Santiago Lima1, Marianne Hoogeveen-Westerveld1, Akio Nakashima2
1Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Abstract:
The TSC1-TSC2-TBC1D7 complex is an important negative regulator of the mechanistic target of rapamycin complex 1 that controls cell growth in response to environmental cues. Inactivating TSC1 and TSC2 mutations cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterised by the occurrence of benign tumours in various organs and tissues, notably the brain, skin and kidneys. TBC1D7 mutations have not been reported in TSC patients but homozygous inactivation of TBC1D7 causes megaencephaly and intellectual disability. Here, using an exon-specific deletion strategy, we demonstrate that some regions of TSC1 are not necessary for the core function of the TSC1-TSC2 complex. Furthermore, we show that the TBC1D7 binding site is encoded by TSC1 exon 22 and identify amino acid residues involved in the TSC1-TBC1D7 interaction.
Insights
The TSC1-TSC2-TBC1D7 complex regulates cell growth. Researchers found specific TSC1 regions are non-essential, and identified the TBC1D7 binding site on TSC1 exon 22, aiding tuberous sclerosis complex research.
Area of Science:
- Molecular Biology
- Genetics
- Cellular Biology
Background:
- The TSC1-TSC2-TBC1D7 complex is a key negative regulator of mTORC1, controlling cell growth in response to environmental signals.
- Mutations in TSC1 and TSC2 cause tuberous sclerosis complex (TSC), a disorder leading to benign tumors in various organs.
- While TSC1 and TSC2 mutations are linked to TSC, TBC1D7 mutations have not been reported in patients, though homozygous inactivation causes severe neurological conditions.
Purpose of the Study:
- To investigate the functional necessity of specific regions within TSC1 for the TSC1-TSC2 complex's core activity.
- To pinpoint the precise location and molecular interactions of TBC1D7 binding to TSC1.
Main Methods:
- Utilized an exon-specific deletion strategy in TSC1 to assess the impact on complex function.
- Employed biochemical and genetic approaches to identify amino acid residues critical for the TSC1-TBC1D7 interaction.
Main Results:
- Demonstrated that certain regions of TSC1 are dispensable for the core function of the TSC1-TSC2 complex.
- Confirmed that TSC1 exon 22 encodes the binding site for TBC1D7.
- Identified specific amino acid residues mediating the interaction between TSC1 and TBC1D7.
Conclusions:
- The findings refine our understanding of the TSC1-TSC2-TBC1D7 complex structure-function relationship.
- This detailed molecular insight could inform future therapeutic strategies for TSC and related disorders.
